In 2002, for example, Genentech and its marketing partners, took in total revenues of more than $1 billion for Rituxan, an antibody-based lymphoma drug.

• 抗体药物的制造是产业界最活跃的部门之一，例如在2002年，单是Rituxan这种用来治疗淋巴瘤的抗体药物，就为基因科技与其行销夥伴带来超过10亿美元的营业额。